S
4
Investments
2
Exits
—
AUM
50.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sagard.
Investment Thesis & Strategy
Sagard, as a private equity firm, invests in various stages of fintech companies, seeking to provide capital and strategic guidance to accelerate growth and generate returns.
Investment Activity
Deals per year over the last 6 years
1
20161
20172
20183
20190
20203
2021Portfolio Companies
Selected investments from their portfolio of 4 companies
B
Blue Owl Capital
Fintech · Growth, 2021
e
e2open
Enterprise · Growth, 2021
W
Weave
SaaS · Series C+, 2021
C
Coveo
SaaS · Growth, 2019
K
Kry
Healthcare · Growth, 2019
G
Groupe CHC
Healthcare · Growth, 2019
K
KindredBio
Biotech · Growth, 2018
B
Blink Charging
Transportation · Growth, 2018
A
Altas Partners
Other · Growth, 2017
L
Lytx
Transportation · Growth, 2016
Frequently Asked Questions
Sagard focuses on Series B, Series C+ stage investments.